Diabetes mellitus is characterized by several abnormalities of the vascular endothelium. The cellular events leading to the abnormalities of vascular endothelium in diabetes are poorly understood. It has recently been demonstrated that vascular endothelial cells interact at several levels with insulin and the insulin-like growth factors, protein hormones whose metabolism is central to the diabetic conditions. These interactions result in two major events: (1) the protein hormones modulate several specific endothelial functions and (2) the endothelial cells transport the hormones to their tissue sites of action. Studies in this proposal are designed to determine the specialized properties of endothelial cells that allow the cell to subserve these two functions. In a series of biochemical and morphological studies, it will be specifically determined (1) whether endothelial cells possess unusual receptor subtypes, (2) the specialized complexing of internalized insulin and IGFs with other proteins, (3) the presence of unusual messenger RNAs for insulin receptors, (4) the role of serum and endogenously produced IGF-binding proteins in IGF action and transport, (5) the endothelial cell transport of insulin and IGF in diabetic conditions, and (6) the endothelial transcellular transport of insulin and the IGFs at the ultrastructural level. Thus, taken together, these studies should define the mechanisms for the uptake, function, and transport of insulin and the insulin-like growth factors by vascular endothelium in normal and diabetic states.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK025421-09
Application #
3227396
Study Section
Endocrinology Study Section (END)
Project Start
1979-04-01
Project End
1992-03-31
Budget Start
1987-04-01
Budget End
1988-03-31
Support Year
9
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Iowa
Department
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Dake, Brian L; Boes, Mary; Bach, Leon A et al. (2004) Effect of an insulin-like growth factor binding protein fusion protein on thymidine incorporation in neuroblastoma and rhabdomyosarcoma cell lines. Endocrinology 145:3369-74
Boes, Mary; Dake, Brian L; Booth, Barbara A et al. (2003) IGF-I and IGFBP-3 transport in the rat heart. Am J Physiol Endocrinol Metab 284:E237-9
Booth, B A; Boes, M; Dake, B L et al. (2002) IGFBP-3 binding to endothelial cells inhibits plasmin and thrombin proteolysis. Am J Physiol Endocrinol Metab 282:E52-8
Boes, M; Dake, B L; Booth, B A et al. (2002) Structure-function relationships of insulin-like growth factor binding protein 6 (IGFBP-6) and its chimeras. Growth Horm IGF Res 12:91-8
Knudtson, K L; Boes, M; Sandra, A et al. (2001) Distribution of chimeric IGF binding protein (IGFBP)-3 and IGFBP-4 in the rat heart: importance of C-terminal basic region. Endocrinology 142:3749-55
Oltman, C L; Kane, N L; Gutterman, D D et al. (2000) Mechanism of coronary vasodilation to insulin and insulin-like growth factor I is dependent on vessel size. Am J Physiol Endocrinol Metab 279:E176-81
Booth, B A; Boes, M; Dake, B L et al. (2000) Effect of IGFBP-derived peptides on incorporation of(35)SO(4)into proteoglycans. Growth Horm IGF Res 10:224-9
Boes, M; Dake, B L; Booth, B A et al. (1999) Connective tissue growth factor (IGFBP-rP2) expression and regulation in cultured bovine endothelial cells. Endocrinology 140:1575-80
Booth, B A; Boes, M; Dake, B L et al. (1999) Isolation and characterization of plasmin-generated bioactive fragments of IGFBP-3. Am J Physiol 276:E450-4
Sandra, A; Boes, M; Dake, B L et al. (1998) Infused IGF-I/IGFBP-3 complex causes glomerular localization of IGF-I in the rat kidney. Am J Physiol 275:E32-7

Showing the most recent 10 out of 25 publications